Evidence map›Paper›PMID 39701207›Full record

ArticleContraception2025

Healthcare provider communication and current contraceptive use among transgender men and gender-diverse people: Results from an online, cross-sectional survey in the United States.

Jasmine Berry, Juno Obedin-Maliver, Sachiko Ragosta, Jen Hastings, Mitchell R Lunn, Annesa Flentje, Matthew R Capriotti, Zubin Dastur, Micah E Lubensky, Elizabeth M Inman and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Contraception, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jasmine BerryDepartment of Epidemiology, Rollins School of Public Health, Atlanta, GA, United States.
Juno Obedin-MaliverDepartment of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, United States; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, United States; The PRIDE Study/PRIDEnet, Stanford University, Palo Alto, CA, United States.
Sachiko RagostaIbis Reproductive Health, Oakland, CA, United States.
Jen HastingsUniversity of California, San Francisco, Department of Family and Community Medicine, San Francisco, CA, United States.
Mitchell R LunnDepartment of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, United States; The PRIDE Study/PRIDEnet, Stanford University, Palo Alto, CA, United States; Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Annesa FlentjeThe PRIDE Study/PRIDEnet, Stanford University, Palo Alto, CA, United States; Department of Community Health Systems, University of California, San Francisco, CA, United States; Alliance Health Project, Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, CA, United States.
Matthew R CapriottiThe PRIDE Study/PRIDEnet, Stanford University, Palo Alto, CA, United States; Department of Psychology, San José State University, San Jose, CA, United States.
Zubin DasturDepartment of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, United States; The PRIDE Study/PRIDEnet, Stanford University, Palo Alto, CA, United States.
Micah E LubenskyThe PRIDE Study/PRIDEnet, Stanford University, Palo Alto, CA, United States; Department of Community Health Systems, University of California, San Francisco, CA, United States.
Elizabeth M InmanStony Brook University, Department of Psychology, Stony Brook, NY, United States.
Heidi MosesonIbis Reproductive Health, Oakland, CA, United States. Electronic address: hmoseson@ibisreproductivehealth.org.

Funding

UCSF-Kaiser Urological Epidemiology Research Career Development ProgramK12DK111028 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUANG, ALISON · 2016 to 2025
$5.3M
Advancing novel survey tools to increase participation and improve sexual and reproductive health data qualityR01HD109320 · NICHD · IBIS REPRODUCTIVE HEALTH · PI Heidi Serene Moseson Lidow · 2023 to 2026
$2.1M
Gene expression outcomes in interventions for substance using HIV+ minority menK23DA039800 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FLENTJE, ANNESA · 2015 to 2019
$1.0M
NICHD NIH HHS R01 HD109320NIDA NIH HHS K23 DA039800NIDDK NIH HHS K12 DK111028
6 · The paper itself

Abstract

objectivesTo explore whether discussing contraceptive use with a healthcare provider is associated with current contraceptive use among transgender men and gender-diverse (TMGD) individuals. STUDY

designIn 2019, we conducted a cross-sectional survey among transgender men and gender-diverse adults in the United States who were assigned female or intersex at birth. We measured whether respondents had ever discussed contraception with a healthcare provider as well as current use of contraception, reasons for use, and barriers to use. We described frequencies and ranges for key variables and implemented a series of nested logistic regression models to evaluate the association between ever having spoken to a provider about contraception and current use of contraception for any reason, overall and by method type.

resultsAmong 1694 respondents, about half (48%) were currently using a method of contraception for any reason, most commonly barrier methods (17%) and long-acting-reversible-contraception (LARC) (17%). Compared to those who never had a conversation about contraception with a provider, respondents who spoke with a provider were more likely to be currently using contraception - particularly among those who self-initiated the conversation (aOR: 3.8, 95% CI: 2.5-5.6). Having discussed contraception with a healthcare provider was most strongly associated with current LARC use.

conclusionsHaving had a conversation with a provider about contraception use was positively associated with current contraception use among a large, national sample of transgender men and gender-diverse people. Facilitating patient participation in contraception counseling for transgender and gender-diverse patients should be emphasized in provider training. IMPLICATIONS: Given formidable barriers to healthcare faced by TMGD people, training providers on how to initiate affirming and relevant conversations with TMGD patients about contraceptive needs and preferences is essential, as are efforts to educate and empower TMGD individuals to advocate for the information they need in these interactions.

Indexed as

CommunicationContraceptionContraception BehaviorHealth PersonnelPhysician-Patient RelationsTransgender PersonsAdolescentAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedSurveys and QuestionnairesUnited StatesYoung AdultCommunicationContraceptionGender-diverseGender minorityHealthcare providersPatient-centered care

Identifiers

PMID39701207
PMCPMC12054636

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.